✦ LIBER ✦

PDB6 PREVENTION OF TYPE 2 DIABETES IN THE USA: COST-EFFECTIVENESS ISSUES

✍ Scribed by AJ Palmer; S Roze

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PDB6 THE COST OF TYPE-2 DIABETES IN UKRA

✍ ON Zaliska; AI Boyko 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

PDB27 THE COST-EFFECTIVENESS OF INSULIN

✍ J Walczak; W Dardzinski; M Kusy; J Lis; G Nogas 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

PDB28 THE COST-EFFECTIVENESS ANALYSIS OF

✍ J Walczak; G Nogas; E Gebus; D Pawlik; K Pacocha 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

PDB46 COST-EFFECTIVENESS OF NEW ANTIDIAB

✍ S Baytar; S Malhan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

PDB28 COST-EFFECTIVENESS ANALYSIS OF ACA

✍ K JongMann; JP Clegg; K Chang; P JuYeol; KU Wittrup-Jensen; WJ Valentine 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

PDB53 Cost-Effectiveness of Saxagliptin

✍ A. Juarez-Garcia; D. Casalvolone; L. Qatami; K. Bergenheim; B.M.K. Donato 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB